Increased visinin-like protein-1, YKL-40, lipocalin-2, and IL-23 levels in patients with migraine
- PMID: 36526441
- DOI: 10.1080/01616412.2022.2156125
Increased visinin-like protein-1, YKL-40, lipocalin-2, and IL-23 levels in patients with migraine
Abstract
Background: Migraine is a type of primary headache caused by changes in the trigeminal system and has been reported to be associated with neurovascular inflammation of cerebral and extracerebral vessels.
Objective: It is known that inflammation is an important process in the pathogenesis of migraine. It has been shown that the molecules of visinin-like protein 1 (Vilip-1), YKL-40, lipocalin-2 and interleukin (IL)-23 play a role in the inflammatory process. Our aim is to investigate the role of this molecule in the metabolic pathway of migraine disease.
Methods: Fifty migraine patients with and without aura in the interictal period were included in the study. Vilip-1, YKL-40, lipocalin-2, and IL-23 levels were measured by ELISA method.
Results: Serum vilip-1, YKL-40, lipocalin-2, and IL-23 levels were found to be significantly higher in migraine patients compared to the control group. We found that this molecule increased significantly in migraine subgroups compared to the control group (p < 0.001). A positive significant correlation was found between vilip-1 level and YKL-40 and lipocalin-2 levels in migraine patients. In addition, a positive correlation was observed between visual analogue scale score, number of days with pain and vilip-1 level (p < 0.01). The results of our study showed that activation of inflammatory mediators may play a role in the pathogenesis of migraine disease. In addition, our study is valuable in that inflammatory molecules are high in the interictal period and these biomarkers have never been analyzed in migraine patients. However, we still believe that larger studies are needed to explain the role of vilip-1, YKL-40, lipocalin-2, and IL-23 in the molecular mechanism of migraine disease.
Keywords: IL-23; Migraine; YKL-40; inflammation; lipocalin-2; vilip-1.
Similar articles
-
Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.Neurology. 2021 May 18;96(20):e2546-e2557. doi: 10.1212/WNL.0000000000011937. Epub 2021 Apr 1. Neurology. 2021. PMID: 33795390 Free PMC article.
-
A meta-analysis on the levels of VILIP-1 in the CSF of Alzheimer's disease compared to normal controls and other neurodegenerative conditions.Aging Clin Exp Res. 2021 Feb;33(2):265-272. doi: 10.1007/s40520-019-01458-2. Epub 2020 Jan 14. Aging Clin Exp Res. 2021. PMID: 31939203 Review.
-
Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.Transl Neurodegener. 2018 Sep 10;7:23. doi: 10.1186/s40035-018-0127-7. eCollection 2018. Transl Neurodegener. 2018. PMID: 30311914 Free PMC article.
-
The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.J Alzheimers Dis. 2015;47(1):17-32. doi: 10.3233/JAD-150060. J Alzheimers Dis. 2015. PMID: 26402751 Review.
-
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.Alzheimers Res Ther. 2015 Sep 17;7(1):59. doi: 10.1186/s13195-015-0142-1. Alzheimers Res Ther. 2015. PMID: 26383836 Free PMC article.
Cited by
-
Astrocyte-Microglia Crosstalk: A Novel Target for the Treatment of Migraine.Aging Dis. 2024 May 7;15(3):1277-1288. doi: 10.14336/AD.2023.0623. Aging Dis. 2024. PMID: 37450927 Free PMC article. Review.
-
Migraine, Allergy, and Histamine: Is There a Link?J Clin Med. 2023 May 19;12(10):3566. doi: 10.3390/jcm12103566. J Clin Med. 2023. PMID: 37240671 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous